Oxford Immunotec Global PLC | Key People and Executives
Peter James Wrighton-Smith
Chief Executive Officer & Executive Director
Patricia Randall
Non-Executive Director
Richard Alvin Sandberg
Chairman
Mark R. Klausner
Independent Director
Herman Rosenman
Independent Non-Executive Director
Patrick J. Balthrop
Independent Non-Executive Director
Andrew Scott Walton
Independent Non-Executive Director
James R. Tobin
Independent Non-Executive Director
Ronald Asbury Andrews
Independent Non-Executive Director
Peter James Wrighton-Smith
Chief Executive Officer & Executive Director
Stefan C. Linn
Chief Operating Officer
Richard M. Altieri
Chief Financial & Accounting Officer
Richard J. Wenstrup
Chief Medical Officer
Jeff R. Schroeder
President-Strategic Accounts
Patricia Randall
Non-Executive Director
Karen Koski
Head-Investor & Media Relations
Elizabeth M. Keiley
Secretary, Senior Vice President & General Counsel
Richard Alvin Sandberg
Chairman
Mark R. Klausner
Independent Director
Herman Rosenman
Independent Non-Executive Director
Patrick J. Balthrop
Independent Non-Executive Director
Andrew Scott Walton
Independent Non-Executive Director
James R. Tobin
Independent Non-Executive Director
Ronald Asbury Andrews
Independent Non-Executive Director
| Address |
Milton Park
Abingdon Oxfordshire OX14 4RZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://oxfordimmunotec.com |
| Updated |
07/08/2019 |
| Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT. |
